Kristian Alda Sianipar

Cervical cancer remains a major public health burden, particularly in developing countries, with low screening coverage contributing to late diagnosis. Human papillomavirus (HPV) DNA testing is a highly

sensitive screening method, and self-sampling has emerged as a potential alternative to clinician-based sampling, offering increased accessibility and acceptability. This study aimed to evaluate the diagnostic performance and patient acceptability of HPV DNA self-sampling compared to clinician sampling.